Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,790 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of the effects of pretreatment with tirofiban, clopidogrel or both on the inhibition of platelet aggregation and activation in patients with acute coronary syndromes.
Solinas E, Gobbi G, Dangas G, Mehran R, Fahy M, Ippolito L, Bolognesi MG, Ruenes R, Merlini PA, Ardissino D, Vitale M. Solinas E, et al. Among authors: mehran r. J Thromb Thrombolysis. 2009 Jan;27(1):36-43. doi: 10.1007/s11239-007-0174-x. Epub 2007 Nov 30. J Thromb Thrombolysis. 2009. PMID: 18049795 Clinical Trial.
Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation.
Lansky AJ, Dangas G, Mehran R, Desai KJ, Mintz GS, Wu H, Fahy M, Stone GW, Waksman R, Leon MB. Lansky AJ, et al. Among authors: mehran r. J Am Coll Cardiol. 2002 Jan 16;39(2):274-80. doi: 10.1016/s0735-1097(01)01745-4. J Am Coll Cardiol. 2002. PMID: 11788219 Free article. Clinical Trial.
Coronary artery stenting.
Ashby DT, Dangas G, Mehran R, Leon MB. Ashby DT, et al. Among authors: mehran r. Catheter Cardiovasc Interv. 2002 May;56(1):83-102. doi: 10.1002/ccd.10209. Catheter Cardiovasc Interv. 2002. PMID: 11979540 Review. No abstract available.
Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions.
Costantini CO, Lansky AJ, Mintz GS, Shirai K, Dangas G, Mehran R, Fahy M, Slack S, Coral M, Teirstein PS, Waksman R, Stone G, Moses J, Leon MB. Costantini CO, et al. Among authors: mehran r. J Am Coll Cardiol. 2003 May 21;41(10):1725-31. doi: 10.1016/s0735-1097(03)00298-5. J Am Coll Cardiol. 2003. PMID: 12767655 Free article. Clinical Trial.
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Tcheng JE, Kandzari DE, Grines CL, Cox DA, Effron MB, Garcia E, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Fahy M, Lansky AJ, Mehran R, Stone GW; CADILLAC Investigators. Tcheng JE, et al. Among authors: mehran r. Circulation. 2003 Sep 16;108(11):1316-23. doi: 10.1161/01.CIR.0000087601.45803.86. Epub 2003 Aug 25. Circulation. 2003. PMID: 12939213 Clinical Trial.
Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients >or=75 years of age versus those <75 years of age.
Iakovou I, Dangas G, Mehran R, Mintz GS, Lansky AJ, Aymong ED, Nikolsky E, Vagaonescu T, Glasser LA, Stone GW, Leon MB, Moses JW. Iakovou I, et al. Among authors: mehran r. Am J Cardiol. 2003 Nov 1;92(9):1083-6. doi: 10.1016/j.amjcard.2003.07.007. Am J Cardiol. 2003. PMID: 14583360
1,790 results